iRhythm Holdings, Inc.
Every calculator, already run for IRTC
Open the full toolkit →You have the numbers on IRTC. Get the argument.
A written report on which of these readings actually decide the outcome for iRhythm Holdings, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
15 analysts covering IRTCAnalyst Price Target Disagreement for iRhythm Holdings, Inc.
Wall Street's bull case implies +79% from the current price; the bear case implies +44%. A 36% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for IRTC
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About iRhythm Holdings, Inc.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consis…
IRTC — frequently asked
Is IRTC a buy right now?
Wall Street's consensus rating on iRhythm Holdings, Inc. is Strong Buy across 15 analysts, with a mean price target of $176.14 (+61% vs. the current $109.33). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is IRTC overvalued?
IRTC trades at — trailing earnings, against a DCF fair value of $46 per share. The current price implies 18% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is IRTC's next earnings date?
iRhythm Holdings, Inc. is next scheduled to report earnings around Nov 5, 2026. A full IRTC research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for iRhythm Holdings, Inc.?
Analysts covering iRhythm Holdings, Inc. (IRTC) range from a bear-case target of $157.00 to a bull-case high of $196.00, with a mean consensus target of $176.14 across 14 analysts. The spread of $39.00 (36% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare iRhythm Holdings, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For iRhythm Holdings, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full IRTC research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on iRhythm Holdings, Inc., in minutes. 3 free reports included with every account — no credit card required.